The battle against viruses and infections goes into overdrive this week, with the release of the long-awaited Israeli-invented nasal spray that kills 99.99% of all viruses in 2 minutes.
The over-the-counter spray called Enovid also known as VirX was developed by the joint Israel-Canada biotech startup SaNOtize established by Dr. Gilly Regev and Dr. Chris Miller.
Enovid’s Nitric Oxide Nasal Spray (NONS) blocks the entry of viruses and halts viral replication within the nasal cavity. This rapidly reduces the total viral load which is linked to the level of infectivity. It can prevent transmission and lower the severity of infection.
Dr. Regev is an experienced biotech executive with hands-on experience in drug development and biochemistry R&D with 12 years’ work in the field of nitric oxide. Dr. Miller is a pioneer in nitric oxide technology and therapeutic research with 20 years of expertise in clinical trials.
The special features of Nitric Oxide (NO) form the basis of the innovative products that SaNOtize has developed to treat a wide range of previously difficult or untreatable medical problems.
Dr. Regev calls Enovid “a hand sanitizer equivalent for the nose.” It creates a chemical barrier of nitric oxide, which is known for its antiviral and antimicrobial qualities. As well, it forms a physical barrier in the nasal passages to stop viruses and microbes from finding a surface to penetrate. “The nitric oxide means this is a special spray that doesn’t just block viruses but actually kills them,” she said. For several years, even before the pandemic outbreak of COVID-19, the scientists at SaNOtize were conducting highly advanced research into the potential of nitric oxide to act as a unique treatment for bacterial and viral infections.
Five common misbeliefs about COVID-19 and vaccines
Do people let false claims about health issues get in their way? It is quite disturbing to learn that reliable
Read More »